EVENT DETAILS
Tuesday, October 2, 2018
Red Lion Hotel
100 Berlin Road,
Cromwell, CT 06416
Time
8:00 AM - 5:00 PM
Total Credits
7 Contact Hour(s)
Target Audience
Pharmacist , Pharmacy Technician
Cost
$129.00
Registration closes on 10/1/2018 at 11:00 PM
 

Registration will be held from 8:00 am - 8:30 am. Continental breakfast will be served during this time.

A plated lunch will be served from 12:00 pm - 1:00 pm.

Refreshments will be served during the afternoon programs.

 

AGENDA

Scheduled CE Activities Tuesday, October 2, 2018
  
 
 
Pharmacist Learning Objectives
  • Identify the epidemiology of HIV/AIDS in Connecticut
  • List the current and new HIV Treatments
  • Determine the basic science associated with treatment as prevention
  • Recognize the issues and importance of ARVs and resistance
Pharmacy Technician Learning Objectives
  • Identify the epidemiology of HIV/AIDS in Connecticut
  • List the current and new HIV Treatments
  • Determine the basic science associated with treatment as prevention
  • Recognize the issues and importance of ARVs and resistance
 
Faculty
A.C DemidontMD
Assistant Clinical Professor of Medicine, Quinnipiac University's Frank K. Netter School of Medicine and Yale University School of Nursing
 
ACPE UAN
0280-9999-18-075-L02-P (Knowledge-Based)
0280-9999-18-075-L02-T (Knowledge-Based)
 
Credits
1.5
 
 
Supported By
New England AIDS Education Training Center
 
Traditionally, the profession of pharmacy has been deemed to be, in a large part, a ‘self-regulated’ profession.  This regulatory structure, however, has not been without criticism and controversy.  This session seeks to examine the various mechanisms in place for the assurance of professional quality.  It examines instances where ‘self-governance’ models have toppled and how those instances have changed the face of the profession.  The evolving role of the pharmacy technician is carefully examined within the context of ‘self-governance’, giving rise to radically different expectations and standards from one state to the next.   Ultimately, the session asks participants to critically examine the profession and to identify the challenges and responsibility inherent to maintaining an effective regulatory system. 
 
 
Pharmacist Learning Objectives
  • Recognize the role and authority of the state board of pharmacy in regard to the assurance of professional competence
  • Identify the advantages and disadvantages of self-regulated systems in pharmacy practice
  • Recognize the variability and challenges associated with assessing in the competence of pharmacy technicians in the United States
Pharmacy Technician Learning Objectives
  • Recognize the role and authority of the state board of pharmacy in regard to the assurance of professional competence
  • Identify the advantages and disadvantages of self-regulated systems in pharmacy practice
  • Recognize the variability and challenges associated with assessing in the competence of pharmacy technicians in the United States
 
Faculty
Kevin HopeRPh
Clinical Education Specialist and Continuing Education Administrator, PharmCon, Inc.; Advisory Board Member, Paradigm Education Solutions; Nuclear Pharmacist, Triad Isotopes
 
ACPE UAN
0280-0000-18-072-L03-P (Knowledge-Based)
0280-0000-18-072-L03-T (Knowledge-Based)
 
Credits
1.5
 
 
Supported By
American Health Resources, LLC.
 
The session will begin with a background overview of COPD including clinical presentation, pathogenesis, and diagnosis.  The presentation will focus on the recent 2017 update of the Global Initiative for Chronic Obstructive Lung Disease (GOLD) guidelines with regards to the classification of disease severity and recommended pharmacologic management including information on many newly approved COPD medications and inhaler device types. Participants will benefit from demonstrations of the various inhaler devices so they may in turn educate patients in the pharmacy to improve self-management.
 
 
Pharmacist Learning Objectives
  • Outline the clinical presentation and spirometry parameters used in the diagnosis of COPD
  • Identify the appropriate treatment regimen based on patient specific factors and disease assessment in accordance with the 2017 GOLD Report
  • Describe pharmacist driven interventions which can improve health status and reduce future exacerbations
  • Demonstrate and evaluate the proper use of various inhalation devices to support patient self-management education
Pharmacy Technician Learning Objectives
  • Recognize the latest concepts in the etiology and pathophysiology of COPD
  • Identify the rationale for the available pharmacological treatments
  • List the effects of pharmacological treatment on long term outcomes in COPD
 
Faculty
Nausherwan BurkiMD, PhD, FRCP, FRCPE, FCCP
Professor of Medicine, University of Connecticut Health Center
 
ACPE UAN
0280-0000-18-074-L01-P (Knowledge-Based)
0280-0000-18-074-L01-T (Knowledge-Based)
 
Credits
2
 
 
Supported By
American Health Resources, LLC.
 
Hydroxy-methyl-glutaryl CoA (HMG CoA) reductase inhibitors or statins are well tolerated but associated with various statin associated symptoms (SAS) including statin associated muscle symptoms (SAMS), diabetes mellitus (DM), and central nervous system (CNS) complaints. These are “statin associated symptoms” because they are rare in clinical trials making their causative relationship to statins unclear. SAS are nevertheless important because they prompt dose reduction or discontinuation of these life-saving mediations.  SAMS, is the most frequent SAS,  and mild myalgia may affect 5-10% of statin users. Clinically important muscle symptoms including rhabdomyolysis and  statin-induced necrotizing autoimmune myopathy (SINAM) are rare. SINAM is apparently provoked by antibodies (ABs) against HMG CoA reductase. Good evidence links statins to DM, but evidence linking statins and other SAS is largely anecdotal. Management of SAS requires making the possible diagnosis, altering or discontinuing the statin treatment, and using alternative lipid-lowering therapy.
 
 
Pharmacist Learning Objectives
  • Discuss why statin associated symptoms are a public health problem
  • List 3 possible statin associated symptoms
  • Present an approach to managing statin associated symptoms
Pharmacy Technician Learning Objectives
  • Discuss why statin associated symptoms are a public health problem
  • List 3 possible statin associated symptoms
  • Present an approach to managing statin associated symptoms
 
Faculty
Paul D. ThompsonMD
Chief of Cardiology, Hartford Hospital
 
ACPE UAN
0280-0000-18-071-L01-P (Knowledge-Based)
0280-0000-18-071-L01-T (Knowledge-Based)
 
Credits
1
 
 
Supported By
American Health Resources, LLC.
 
Patients with type 2 diabetes mellitus (T2DM) are at high risk for cardiovascular disease (CVD). Based upon results of multiple cardiovascular outcomes trials (CVOT), the American Diabetes Association (ADA) most recent guidelines have recommended new treatment options to include a medication to improve heart health in those patients with CVD. Pharmacists have an opportunity to recommend an evidence-based, individualized treatment option to providers. This program will review the ADA's newest update to the Standards of Medical Care in Diabetes, summarize the results for CVOTs, and highlight key features of cardioprotective diabetes medications to individualize treatment. 
 
 
Pharmacist Learning Objectives
  • List the new treatment guideline recommendations for patients with diabetes and cardiovascular disease
  • Identify recent clinical trials supporting the potential cardiovascular benefits of diabetes therapies
  • Determine an appropriate glucose-lowering agent based on guidelines, patient preferences, abilities, and resources
Pharmacy Technician Learning Objectives
  • Recognize evidence-based treatment options that have shown cardiovascular protection
  • Identify the cardiovascular benefits and side effects of these medications with patients
 
Faculty
Alaina RotelliPharmD, BCACP
Assistant Professor, Department of Pharmacy Practice & Administration, University of Saint Joseph School of Pharmacy and Physician Assistant Studies
 
ACPE UAN
0280-0000-18-073-L01-P (Knowledge-Based)
0280-0000-18-073-L01-T (Knowledge-Based)
 
Credits
1
 
 
Supported By
American Health Resources, LLC.
 
 
 
 
Requirements for CE Credit
  • Participant Requirement and Statement of Credit: To receive credit, participants must fully attend each session (no partial credit will be awarded), pass in a completed attendance verification form, and using the access code provided, complete the online evaluation for each session attended. Attendance will be verified. All participants will have the opportunity to evaluate the educational sessions and presenters as well as the ability to identify their
  • Pharmacists and Pharmacy Technicians: CE credit will be automatically uploaded to CPE Monitor upon completion of the evaluation and posted to the participant’s NABP account within 72 hours where an official certificate of credit can be printed. Evaluations must be completed within 60 days of program date to receive credit.
  • Statement of Disclosure: Disclosure will be made on the day of the program regarding any interest or affiliation a speaker may have with a supporting organization.
  • Refund Policy: A full refund will be provided only if a written request is received by American Health Resources, LLC at least 48 hours prior to the program or if the program is cancelled. American Health Resources, LLC reserves the right to change the presenters, topics or seminar schedules.
 
Only Certificates of Credit issued from CPE Monitor are valid in the US.
CPE Monitor will not accept credits after 60 days from the session date.
 
Supported By:
American Health Resources, LLC.
 
Registration closes on 10/1/2018 at 11:00 PM
 

CONTINUING EDUCATION

843 488 5550 Office

843 488 5554 Fax

info@ahrevents.com Email

www.ahrevents.com Web

341 Wellness Drive, Myrtle Beach, SC 29579 Address

©2015 PharmCon, lnc. All Rights Reserved | Terms & Conditions | Privacy PolicyAmerican Health Resources, LLC a subsidiary of PharmCon, Inc.
Developed By: ITB, Inc.